Teleflex Incorporated (NYSE:TFX) Stock Holdings Lifted by Blue Trust Inc.

Blue Trust Inc. lifted its position in Teleflex Incorporated (NYSE:TFX) by 51.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 471 shares of the medical technology company’s stock after acquiring an additional 159 shares during the quarter. Blue Trust Inc.’s holdings in Teleflex were worth $84,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Simplify Asset Management Inc. purchased a new stake in shares of Teleflex in the third quarter valued at $4,800,000. JPMorgan Chase & Co. raised its position in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after buying an additional 19,466 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in Teleflex by 19.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock worth $102,000 after acquiring an additional 80 shares in the last quarter. LGT Capital Partners LTD. boosted its position in Teleflex by 4.2% during the 3rd quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock worth $57,300,000 after acquiring an additional 9,411 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its stake in Teleflex by 41.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock valued at $6,010,000 after acquiring an additional 7,132 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 1.4 %

Shares of NYSE:TFX opened at $171.13 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $7.95 billion, a PE ratio of 34.02, a P/E/G ratio of 1.78 and a beta of 1.16. Teleflex Incorporated has a 1 year low of $170.30 and a 1 year high of $256.85. The firm has a fifty day moving average price of $180.48 and a 200 day moving average price of $211.61.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on TFX shares. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Mizuho lowered their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada cut their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Finally, Truist Financial reduced their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.